ResMed shares rise on strong Q2 result

Let's see how this sleep treatment company performed during the second quarter.

| More on:
A man holding a cup of coffee puts his thumb up and smiles while at laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ResMed Inc (ASX: RMD) shares are rising on Friday morning.

At the time of writing, the sleep disorder treatment company's shares are up 0.5% to $40.70.

This follows the release of the company's second quarter update before the market open.

ResMed shares higher on Q2 update

For the three months ended 31 December, ResMed reported a 10% increase in revenue to US$1.3 billion. This was ahead of the US$1,265 million that Goldman Sachs was forecasting for the three months.

This reflects increased demand for the company's sleep devices and masks portfolio, as well as solid growth across its Residential Care Software business.

Revenue in the Americas, excluding Residential Care Software, grew by 12%. Whereas revenue in Europe, Asia, and other markets, excluding Residential Care Software, grew by 8% in constant currency. Finally, Residential Care Software revenue increased by 8% on a constant currency basis.

ResMed revealed that its gross margin increased by 300 basis points mainly due to manufacturing and logistics efficiencies and component cost improvements. Non-GAAP gross margin increased by 230 basis points due to the same factors.

This ultimately led to ResMed reporting a 52% increase in income from operation to US$417.2 million and a 29% jump in non-GAAP net income to US$358.3 million. The latter was ahead of Goldman's estimate of US$349 million.

Management commentary

ResMed chair and CEO Mick Farrell was pleased with the company's performance during the quarter. He said:

Our second quarter fiscal year 2025 top-line growth, margin expansion, and double-digit EPS growth were the result of increased demand for our sleep health and breathing health products and digital health solutions that people love, as well as our laser-focus on operational excellence.

We delivered 10% year-over-year revenue growth, 230 bps improvement in gross margin, and $309 million of operating cash flow. These results are a continuation of the incredible commitment from our team to create a clear market-leading value proposition in connected digital health.

Farrell also spoke positively about the company's future and believes that ResMed is well-placed for growth. This is being supported by smart watches now being able to diagnose sleep apnoea, which could drive increased awareness. He said:

Our ecosystem is unmatched and ResMed is well-positioned to capitalize on the once-in-a-generation opportunities we have with the recent introduction and adoption of consumer wearables that track sleep health, as well as use of GLP-1 therapies.

We believe these developments will drive increased patient flow as we continue to educate people on the benefits of healthy sleep and breathing, with care delivered right in their own home.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man and a woman sit in front of a laptop looking fascinated and captivated.
Financial Shares

5 ASX 200 financial stocks reporting next week

Earnings season is underway...

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Why is this leading ASX 200 REIT under pressure on Friday?

Investors are pressuring the ASX 200 REIT on Friday. Let’s find out why.

Read more »

A happy young couple celebrate a win by jumping high above their new sofa.
Earnings Results

Nick Scali shares jump 12% on better than expected half year results

How did the furniture retailer perform during the first half? Here's what you need to know.

Read more »

Oil worker using a smartphone in front of an oil rig.
Earnings Results

ASX 200 energy stock tumbles despite 50% dividend boost

The ASX 200 energy stock is under heavy selling pressure on Thursday. But why?

Read more »

Earnings Results

This $27 billion ASX 200 share is jumping on strong quarterly results

Investors are cheering on this giant's quarterly update this morning.

Read more »

Business people discussing project on digital tablet.
Real Estate Shares

REA shares sink after CEO exit overshadows half-year profit beat

A strong result has been offset by news that the company's CEO is stepping down.

Read more »

Three smiling corporate people examine a model of a new building complex.
Earnings Results

2 ASX 300 real estate shares charging higher on half-year results

Did these shares deliver strong results? Let's find out.

Read more »

Woman on the phone at a hardware store.
Industrials Shares

Why this $18 billion ASX 200 stock is lifting off on Wednesday

The ASX 200 company is racing ahead of the benchmark.

Read more »